William Lowery, MD
Gynecologic Oncology · Durham, NCNPI 1063622959
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $56,750 of the $67,466 with a category attached, or 84.1%. AstraZeneca accounts for 91.7% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $42,338 and has fallen 98.5% since, to $640 in 2025. Among gynecologic oncology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 139 payments — averaging $485.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$62K
- Seagen Inc.$4K
- Merck$533
- Eisai Inc.$439
- Intuitive Surgical$264
- Johnson & Johnson$157
- plus $595 from 12 others
What the payments were for
- Consulting fees$3,5845%
- Speaking & faculty fees$56,75084%
- Travel & lodging$3,2585%
- Food & beverage$3,8746%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 66 | $61,895 |
| Seagen Inc. | 1 | $3,584 |
| Merck | 22 | $533 |
| Eisai Inc. | 20 | $439 |
| Intuitive Surgical | 10 | $264 |
| Johnson & Johnson(2 entities) | 3 | $157 |
| Genmab U.S., Inc. | 3 | $151 |
| Sanara Medtech Inc. | 1 | $130 |
| AbbVie | 1 | $100 |
| Clovis Oncology, Inc. | 4 | $69 |
| Corcept Therapeutics | 1 | $29 |
| Foundation Medicine, Inc. | 1 | $21 |
| Stryker | 1 | $19 |
| Bayer | 1 | $18 |
| BD | 1 | $18 |
| Tesaro, Inc. | 1 | $16 |
| Conmed Corporation | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYNPARZA$61,127
- TIVDAK$3,685
- Biasurge$130
- Monarch Platform$107
How this compares
$67,466 in reported general payments places this provider in the 90th percentile of 52 gynecologic oncology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gynecologic oncology in Durham
- Angeles SecordDurham$121K
- Andrew BerchuckDurham$12K
- Haley MossDurham$2K
- Laura HavrileskyDurham$29
- Lucybeth Nieves ArribaWilmington$251K
- Robert NaumannCharlotte$221K
- Erin CraneCharlotte$98K
- Michael SundborgSouthern Pines$85K
- Emma RossiGreensboro$62K
- Jubilee BrownCharlotte$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.